Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof

Details for Australian Patent Application No. 2005236068 (hide)

Owner The Brigham and Women's Hospital, Inc. Beth Israel Deaconess Medical Center, Inc.

Inventors Posner, Marshall R.; Cavacini, Lisa; Pier, Gerald B.; Kelly-Quintos, Casie Anne

Agent Davies Collison Cave

Pub. Number AU-B-2005236068

PCT Pub. Number WO2005/103084

Priority 60/564,105 21.04.04 US

Filing date 21 April 2005

Wipo publication date 3 November 2005

Acceptance publication date 26 April 2012

International Classifications

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

14 December 2006 PCT application entered the National Phase

  PCT publication WO2005/103084 Priority application(s): WO2005/103084

26 April 2012 Application Accepted

  Published as AU-B-2005236068

17 May 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 18 Apr 2012. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2006

30 August 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 18 Apr 2012

6 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005236069-Inhibiting effects of sloughing in wellbores

2005236067-Pattern recognition method for diagnosis of systemic autoimmune diseases